These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11720463)

  • 21. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
    Cutrone R; Lednicky J; Dunn G; Rizzo P; Bocchetta M; Chumakov K; Minor P; Carbone M
    Cancer Res; 2005 Nov; 65(22):10273-9. PubMed ID: 16288015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.
    Magnani C
    Med Lav; 2005; 96(4):347-53. PubMed ID: 16457431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Poliomyelitis vaccine contaminated with SV40 and prior exposure to asbestos: cognitive study in a group of car repair workers].
    Poti S; Bellomo RK; Di Pierri C; L'Abbate N
    G Ital Med Lav Ergon; 2006; 28(2):168-9. PubMed ID: 16805449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
    Engels EA; Viscidi RP; Galloway DA; Carter JJ; Cerhan JR; Davis S; Cozen W; Severson RK; de Sanjose S; Colt JS; Hartge P
    J Natl Cancer Inst; 2004 Sep; 96(18):1368-74. PubMed ID: 15367569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.
    Leithner K; Leithner A; Clar H; Weinhaeusel A; Radl R; Krippl P; Rehak P; Windhager R; Haas OA; Olschewski H
    Orphanet J Rare Dis; 2006 Nov; 1():44. PubMed ID: 17090323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents.
    Kops SP
    Anticancer Res; 2000; 20(6C):4745-9. PubMed ID: 11205211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
    Singer RB
    J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polio vaccines, SV40 and human tumours, an update on false positive and false negative results.
    Elmishad AG; Bocchetta M; Pass HI; Carbone M
    Dev Biol (Basel); 2006; 123():109-17; discussion 119-32. PubMed ID: 16566440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does simian virus 40 cause non-Hodgkin lymphoma? A review of the laboratory and epidemiological evidence.
    Engels EA
    Cancer Invest; 2005; 23(6):529-36. PubMed ID: 16203661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SV40 and human brain tumors.
    Geissler E; Staneczek W
    Arch Geschwulstforsch; 1988; 58(2):129-34. PubMed ID: 2837160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus.
    Milano AF; Singer RB
    J Insur Med; 2007; 39(3):160-6. PubMed ID: 18251374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.
    Strickler HD; Rosenberg PS; Devesa SS; Hertel J; Fraumeni JF; Goedert JJ
    JAMA; 1998 Jan; 279(4):292-5. PubMed ID: 9450713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines.
    Hilleman MR
    Dev Biol Stand; 1998; 94():183-90. PubMed ID: 9776239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas.
    Priftakis P; Bogdanovic G; Hjerpe A; Dalianis T
    Anticancer Res; 2002; 22(3):1357-60. PubMed ID: 12168811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer incidence and mortality in France over the period 1978-2000.
    Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer--a review of the epidemiological evidence.
    Strickler HD; Goedert JJ
    Dev Biol Stand; 1998; 94():235-44. PubMed ID: 9776245
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer and noncancer mortality in populations living near uranium and vanadium mining and milling operations in Montrose County, Colorado, 1950-2000.
    Boice JD; Mumma MT; Blot WJ
    Radiat Res; 2007 Jun; 167(6):711-26. PubMed ID: 17523851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update: cohort mortality study of workers highly exposed to polychlorinated biphenyls (PCBs) during the manufacture of electrical capacitors, 1940-1998.
    Prince MM; Hein MJ; Ruder AM; Waters MA; Laber PA; Whelan EA
    Environ Health; 2006 May; 5():13. PubMed ID: 16716225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cause-specific mortality among five-year survivors of childhood cancer.
    Cardous-Ubbink MC; Heinen RC; Langeveld NE; Bakker PJ; Voûte PA; Caron HN; van Leeuwen FE
    Pediatr Blood Cancer; 2004 Jun; 42(7):563-73. PubMed ID: 15127410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.